Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
304 hedge funds and large institutions have $3.02B invested in Amedisys in 2025 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 113 increasing their positions, 84 reducing their positions, and 35 closing their positions.
49% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 35
35% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 84
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
5% more funds holding
Funds holding: 290 → 304 (+14)
1.41% more ownership
Funds ownership: 97.94% → 99.35% (+1.4%)
4% more capital invested
Capital invested by funds: $2.91B → $3.02B (+$108M)
97% less call options, than puts
Call options by funds: $6.96M | Put options by funds: $205M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$47.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$38.9M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$27.1M |
| 4 |
Millennium Management
New York
|
+$20.3M |
| 5 |
SAMU
SONA Asset Management (US)
New York
|
+$19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$50.7M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$39.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$37.6M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$34.2M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$28.3M |
AMED Hedge Fund Activity: Q1 2025 in Review
304 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2025, worth a combined $3.02B — up 3.7% from $2.91B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new AMED positions and 35 closed out — a net gain of 17 holders — while 113 added to existing stakes and 84 trimmed.
The largest buyer was Bank of America, adding an estimated $47.9M. The largest seller was Pacer Advisors, exiting entirely with an estimated $50.7M sold.
- 304 institutional investors held Amedisys (AMED) as of Q1 2025, up from 290 in Q4 2024.
- Funds reported $3.02B of Amedisys stock for Q1 2025, up 3.7% quarter-over-quarter.
- 52 funds opened new Amedisys positions in Q1 2025 and 35 closed out, a net change of +17 holders.
- The largest Amedisys buyer in Q1 2025 was Bank of America, an estimated $47.9M added.
- The largest Amedisys seller in Q1 2025 was Pacer Advisors, an estimated $50.7M sold.
Based on aggregated 13F filings for Q1 2025.